News

TC Energy Announces Promising Q3 2024 Financial Outcomes

TC Energy Announces Promising Q3 2024 Financial Outcomes

Enhancing Financial Performance in Q3 2024

TC Energy Corporation reported solid financial results for the third quarter, underscoring its commitment to operational excellence and effective project execution. The Company has revised its capital expenditure outlook for 2024, now projecting a range of US$3.9 to US$4.1 billion for the Southeast Gateway pipeline in Mexico. This represents a roughly 11 percent reduction from initial estimates, reflecting efficient project management strategies.

Key Financial Highlights

All financial figures are in Canadian dollars unless otherwise stated.

  • In Q3 2024, TC Energy reported comparable earnings of $1.1 billion or $1.03 per share, representing an increase from $1.0 billion or $1.00 per share in Q3 2023. Additionally, net income attributable to common shares rose to $1.5 billion, up significantly from the net loss of $0.2 billion in 2023.
  • The Company anticipates 2024 comparable EBITDA to reach the upper end of its forecasted range between $11.2 billion and $11.5 billion, with a revised outlook for overall net capital expenditures anticipated to be around $7.4 to $7.7 billion.
  • The successful spinoff of the Liquids Pipelines business during the quarter has enhanced financial flexibility, reducing outstanding long-term debt by approximately $7.6 billion.

Operational Achievements

In its ongoing development efforts, TC Energy achieved significant milestones across various pipeline projects and internal operations. The Southeast Gateway project is on track toward commercial service no later than mid-2025, with strong execution decreasing overall costs. The Company is also witnessing solid demand for its natural gas products across North America, with supply deliveries from Canadian Natural Gas Pipelines increasing by 2 percent year-over-year.

Impressive Pipeline Performance

  • Canada Natural Gas Pipelines achieved an average delivery rate of 22.2 Bcf/d, indicating robust operational management and capacity enhancements.
  • U.S. Natural Gas Pipelines reported a daily average flow of 25.9 Bcf/d, continuing a growth trend alongside record quarterly deliveries to power generators.
  • Mexico’s pipeline segment reported flows averaging 3.2 Bcf/d, marking a notable milestone as deliveries to LNG facilities commenced.

Future Growth Strategy

Looking ahead, TC Energy is firmly committed to judicious capital allocation and maintaining its focus on strategic growth initiatives. With significant investments planned, including the anticipated placement of approximately $7 billion worth of projects into service throughout 2024, the Company is well-positioned to achieve its long-term financial objectives.

The operational results highlight TC Energy's emphasis on safety and efficiency, with a strong debt-to-EBITDA target projection of 4.75 times by year-end. This strategy underscores its commitment to not only maintaining but enhancing its value proposition for investors as well as aligning with sustainable practices.

Dialogue with Investors

TC Energy invites stakeholders to join the upcoming teleconference and webcast to discuss its third quarter results, ensuring transparency and engagement with the investment community. Attendees will include the Company’s President and CEO, along with key executives who will address inquiries and elaborate on future directions.

Frequently Asked Questions

What were TC Energy's financial results for Q3 2024?

TC Energy reported comparable earnings of $1.1 billion, or $1.03 per share, and net income attributable to common shares of $1.5 billion.

How did the capital expenditures change for 2024?

The capital expenditure outlook for 2024 has been revised to $7.4 to $7.7 billion, reflecting strong project management.

What is the status of the Southeast Gateway pipeline?

The Southeast Gateway pipeline is on track for commercial service by mid-2025, with capital costs reduced to $3.9 to $4.1 billion.

When will TC Energy hold its teleconference regarding Q3 results?

The teleconference will take place on a scheduled date, presenting insights on financial results and future strategies.

How does the spinoff of the Liquids Pipelines business impact TC Energy?

The spinoff has strengthened financial flexibility, reducing the Company's long-term debt significantly and positioning it for enhanced performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading